FOR IMMEDIATE RELEASE
OLDWICK – AUGUST 18, 2017
The U.S. life/health industry’s Credit Rating activity over the first half of 2017 saw upgrades slightly outpace downgrades, as opposed to first-half 2016 when the number of upgrades and downgrades remained relatively balanced, according to a new A.M. Best special report.
The Best’s Special Report, “Life/Health Sector Rating Upgrades Slightly Outpace Downgrades in First-Half 2017,” states that the year-over-year change in Long-Term Issuer Credit Rating (Long-Term ICR) development was due to improving levels of risk-adjusted capital among life/annuity carriers, driven partially by benign credit market conditions and favorable equity markets, which acted as a tailwind for earnings in 2016. However, a persistently low interest rate environment and a lack of substantial organic growth continued to pressure the earnings of several life/annuity insurers.
In December 2016, A.M. Best revised its outlook on the U.S. life/annuity segment to negative from stable. The driving factors behind the negative outlook were the expectation of depressed premiums, hindered capital growth and struggle to interact with policyholders more quickly and efficiently. A.M. Best also maintains a negative outlook on the U.S. health sector, mainly due to the ongoing impact of The Patient Protection and Affordable Care Act. Still, affirmations remained the most common rating action for the U.S. life/health industry at 78%, consistent with most years.
The number of Long-Term ICR upgrades and downgrades increased over the same period a year ago. A.M. Best reported 15 upgrades and 13 downgrades among life/annuity and health carriers through June 30, 2017, compared with seven upgrades and seven downgrades in first-half 2016. Although the health segment reported improved earnings at year-end 2016, the health insurance exchange population continues to consist of higher-risk and greater utilizers of services, which has adversely impacted earnings and led to higher premiums and added pressure to levels of risk-adjusted capital. As a result, health insurer downgrades continued to exceed upgrades through the first half of 2017.
The proportion of life/annuity and health carriers with stable outlooks increased to 87% in first-half 2017 from 82% in first-half 2016. Additionally, the percentage of ratings under review decreased to 3% from 8%. The proportion of positive outlooks declined slightly, while negative outlooks increased. The outlook was stable for 88.5% of the life/annuity segment and 84.1% of the health segment. In addition to having fewer ratings under review, health carriers had slightly fewer positive outlooks and slightly more negative outlooks than life/annuity carriers.
A.M. Best will continue to monitor closely earnings, premium trends and risk-adjusted capital levels over the remainder of this year, as well as hold discussions with company managements regarding their plans for 2018, in the U.S. life/annuity and health markets.
To access the full copy of this special report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=264691 .
A.M. Best is the world’s oldest and most authoritative insurance rating and information source.
European Union Disclosures
A.M. Best – Europe Rating Services Limited (AMBERS), a subsidiary of A.M. Best Rating Services, Inc., is an External Credit Assessment Institution (ECAI) in the European Union (EU). Therefore, credit ratings issued and endorsed by AMBERS may be used for regulatory purposes in the EU as per Directive 2006/48/EC.
Australian Disclosures
A.M. Best Asia-Pacific Limited (AMBAP), Australian Registered Body Number (ARBN No.150375287), is a limited liability company incorporated and domiciled in Hong Kong. AMBAP is a wholesale Australian Financial Services (AFS) Licence holder (AFS No. 411055) under the Corporations Act 2001. Credit ratings emanating from AMBAP are not intended for and must not be distributed to any person in Australia other than a wholesale client as defined in Chapter 7 of the Corporations Act. AMBAP does not authorize its Credit Ratings to be disseminated by a third-party in a manner that could reasonably be regarded as being intended to influence a retail client in making a decision in relation to a particular product or class of financial product. AMBAP Credit Ratings are intended for wholesale clients only, as defined.
Credit Ratings determined and disseminated by AMBAP are the opinion of AMBAP only and not any specific credit analyst. AMBAP Credit Ratings are statements of opinion and not statements of fact. They are not recommendations to buy, hold or sell any securities or any other form of financial product, including insurance policies and are not a recommendation to be used to make investment /purchasing decisions.
Important Notice: A.M. Best’s Credit Ratings are independent and objective opinions, not statements of fact. A.M. Best is not an Investment Advisor, does not offer investment advice of any kind, nor does the company or its Ratings Analysts offer any form of structuring or financial advice. A.M. Best’s credit opinions are not recommendations to buy, sell or hold securities, or to make any other investment decisions. For additional information regarding the use and limitations of credit rating opinions, as well as the rating process, information requirements and other rating related terms and definitions, please view Understanding Best’s Credit Ratings.
A.M. Best receives compensation for rating related services provided to organizations that it rates. A.M. Best does not offer consulting or advisory services.